VEGFA and diabetic retinopathy: and lutein may serve as a reliable and promising agent for the early intervention of diabetic retinopathy and delay its progression when traditional invasive treatments, such as anti-VEGF injection, laser photocoagulation, and intravitreal steroid therapy, are required.